PharmiWeb7h
Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference
Dr. Anni Wong explains functional and aesthetic nasal corrections. FREEHOLD, NEW JERSEY / ACCESSWIRE / January 7, 2025 / In ...
PharmiWeb1h
Dr. Airica Steed Shares Vision for Transforming Healthcare on the American Journal of Healthcare Strategy Podcast
Dr. Airica Steed Shares Vision for Transforming Healthcare on the American Journal of Healthcare Strategy Podcast CLEVELAND, OH / ACCESSWIRE / January 7, 2025 / The healthcare landscape is undergoing ...
PharmiWeb1h
Laxxon Medical to Participate in 27th Annual Needham Growth Conference
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Laxxon Medical, a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, today announced that management is ...
PharmiWeb10h
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
PharmiWeb9h
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...
PharmiWeb4h
ProteinQure Strengthens Leadership Team with Key Appointments to Accelerate Translational and Clinical Development Programs
TORONTO, ON / ACCESSWIRE / January 7, 2025 / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two distinguished leaders to its team. Dr. Dave Garman has been ...
PharmiWeb4h
OnePoint Patient Care Expands Services to PACE Programs
Experienced pharmacy provider now bringing expert dispensing and personalized support to PACE participants MORTON GROVE, ILLINOIS / ACCESSWIRE / January 7, 2025 / OnePoint Patient Care, a leading ...
PharmiWeb5h
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications ...
PharmiWeb5h
TridentCare and Essence Healthcare Partner to Expand Portable Diagnostic Services to Medicare Advantage Beneficiaries
New partnership will deliver convenient, at-home X-ray and ultrasound services to over 60,000 Medicare Advantage members in Illinois, Missouri, Ohio, Kentucky and Indiana SPARKS, MD and ST. LOUIS, MO ...
PharmiWeb6h
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros ...
PharmiWeb7h
Neuraxpharm to further grow branded business with…
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...
PharmiWeb7h
Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues
Carterra Inc., the world leader in enabling high-throughput biology, announced today that it has sold and shipped its first Carterra Ultra™ biosensor platform. Announced in September 2024, the Ultra ...